FDA Inspection 931673 — Becton, Dickinson And Company, BD Biosciences

Becton, Dickinson And Company, BD Biosciences — FEI 2916837

The FDA completed an inspection of Becton, Dickinson And Company, BD Biosciences on Jun 19, 2015 in San Jose, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 5 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 19, 2015
Fiscal Year
2015
Product Type
Devices
Project Area
Compliance: Devices
Location
San Jose, CA (United States)

Citations

IDCFRDescription
311721 CFR 820.70(i)Software validation for automated processes
316821 CFR 820.198(a)Complaints
317121 CFR 820.198(b)Rationale documented for no investigation
47921 CFR 820.50Purchasing controls, Lack of or inadequate procedures
519521 CFR 1040.10(g)(10)Labels legible, visible, permanent

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.